Exact Sciences' Q4 Revenues Flat, Loss Widens | GenomeWeb

NEW YORK (GenomeWeb News) – Exact Sciences today said that revenues in the fourth quarter were flat year over year, while its net loss widened.

The Madison, Wis.-based firm recorded $1.0 million in revenues for the three months ended Dec. 31, 2012, the same as a year ago and even with the average Wall Street estimate. All revenues came from licensing fees in the recently completed quarter, and the company had no product royalty fees, compared to $6,000 a year ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genetic method to gauge age of ancient samples, genetic polymorphisms in mouse strain, and more.

Two Stanford professors are turning to the online game EteRNA to develop a new way to diagnose tuberculosis.

Lita Nelsen from the Massachusetts Institute of Technology's technology-transfer office is retiring after decades there.

After nine years, the Canadian government is loosening its restrictions on government scientists' ability to speak to the press and public.